Weight loss drugs can cut the risk of early death or hospitalisation in heart patients by half, the largest study of its kind has found. GLP-1 agonists, initially developed for diabetes, showed "dramatic benefits" in protecting heart patients, researchers said at a Madrid conference. According to experts, millions could be prescribed these drugs to live longer and healthier.